A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors.
| Image |  |
|---|---|
| Description | scientific article published on September 2007 |
| Author/s |
author: Carlos Pérez-Plasencia Oscar Arrieta |
| Publication date | September 1, 2007 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |